Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Parkinsonism itself is rarely an emergency, but abrupt onset, focal weakness, acute confusion, fever with rigidity, new inability to swallow, recurrent syncope, severe injury after a fall or rapid deterioration after dopamine-blocking or dopaminergic drug change requires same-day emergency assessment.
Synopsis
Identify parkinsonism clinically, refer suspected Parkinson disease untreated for expert confirmation and detect the temporal, autonomic, ocular, cortical and drug-related clues to alternative diagnoses.
Parkinsonism requires bradykinesia plus rigidity, rest tremor or postural instability not better explained by another disorder; slowness alone is insufficient.
True bradykinesia is progressive reduction in speed or amplitude during repetitive movement, seen in finger tapping, hand opening, pronation-supination, toe tapping or gait.
Idiopathic Parkinson disease usually begins asymmetrically and combines limb signs with reduced arm swing, hypomimia, quiet voice and a good sustained levodopa response.
Key red flags
Acute or stepwise course
Sudden onset, clear focal deficits or stepwise lower-body gait decline is not typical idiopathic Parkinson disease and should trigger stroke, vascular, toxic, metabolic or structural investigation.
Investigation priorities
01
Expert clinical history and examinationFirst step
Confirm bradykinesia, define accompanying signs and compare the longitudinal pattern with recognised Parkinson and atypical criteria.
Management branches
First suspicionRefer before treating
Tremor, stiffness, slowness, gait or balance features raise possible Parkinson disease.
Confirm objective bradykinesia, examine tremor and rigidity, observe gait and eye movements, measure standing blood pressure and screen cognition, mood, swallowing, sleep and falls.
Reconcile prescribed and non-prescribed medicines, plotting dopamine-blocker exposure and symptom onset, and investigate any abrupt, focal or systemic presentation urgently.
Key medicines
No pre-referral dopaminergic trialDo not initiate a diagnostic test dose before specialist assessment when Parkinson disease is newly suspected.
Dopamine-blocking medicine reviewReduce or substitute only through the relevant psychiatric, medical or pharmacy plan; never use abrupt generic withdrawal.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.